Acording to Bloomberg, Guardant Health (GH) exploring an acquisition of NeoGenomics (NEO)
Guardant Health Inc. (GH) is exploring an acquisition of cancer diagnostics and testing firm NeoGenomics Inc. (NEO), according to people familiar with the matter. Update(s):
Read More